Aprogen Medicines Inc. (KRX: 007460)

Market Cap	271.41B
Revenue (ttm)	150.92B
Net Income (ttm)	-48.70B
Shares Out	266.09M
EPS (ttm)	-194.98
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,839,854
Open	1,012.00
Previous Close	1,031.00
Day's Range	1,000.00 - 1,033.00
52-Week Range	701.00 - 1,894.00
Beta	0.83
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 1971
• Employees: 268
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 007460

Financial Performance

In 2023, Aprogen Medicines's revenue was 150.58 billion, an increase of 92.19% compared to the previous year's 78.35 billion. Losses were -55.62 billion, -43.62% less than in 2022.